Phase 4 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who are being monitored and treated in a blood disorder (hematology) unit
- People who have already received their first round of chemotherapy for a type of blood cancer called diffuse large B cell lymphoma or follicular lymphoma
- People whose doctors expect them to live for more than 6 months
- People who have had a negative pregnancy test
- People who have signed the trial consent form
- People who have health insurance
Who may not be able to join:
- People who are receiving certain immune-system-altering treatments (such as monoclonal antibodies or biologic therapies), other than a specific type called anti-CD20 antibodies that are part of their chemotherapy
- People who have had an uncontrolled bacterial, viral, or fungal infection within the last 7 days
- People who have previously received certain pneumonia vaccines called PCV13 or PPV23 — except if PCV13 was given in childhood and the last dose was at least 5 years ago (confirm with trial site)
- People with a pre-existing condition that affects the immune system, such as having had their spleen removed, HIV, an immune deficiency, nephrotic syndrome, sickle cell anaemia, an autoimmune disorder, an organ transplant, or who are taking immune-suppressing medications not part of their chemotherapy
- People who received chemotherapy for any cancer in the 2 years before joining the trial
- People with serious blood clotting disorders that would make a muscle injection unsafe
- People who have previously had a severe allergic (anaphylactic) reaction to a vaccine
- People with a known allergy to any ingredient in the vaccines being studied
- People who are already participating in another vaccine research trial
- People who are legally considered a "protected person" under the relevant regulations (confirm with trial site)
- Women who are pregnant, or women who could become pregnant and are not using appropriate contraception
- People who have received intravenous immunoglobulin (a blood-derived immune treatment) during their follow-up period
- People with a known sensitivity to certain vaccine components, including aluminum phosphate, phenol, or proteins derived from a bacterium called Corynebacterium diphtheriae
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0033 5 49 44 32 76
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients having an immunological response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.